Africa Equity Strategies

Adventis provides investment management and advisory on its Africa ex-SA and Pan-Africa stratagies. These strategies give access to African public equity markets and the attractive investment opportunities listed on local exchanges.
Africa Equity Strategies
Investment Objectives
The Africa ex-SA strategy and Pan-Africa strategy aim to achieve capital growth over the medium to long term by investing in publicly traded companies operating in Africa while managing the downside risks.

The strategies primarily invest in companies listed on African exchanges and may invest in companies listed elsewhere provided they derive a significant amount of their revenue from the region.
Investment Philosophy
Investments should be thoroughly analysed on a fundamental bottom-up basis to determine the quality and risks of the underlying assets

Investments should be purchased at a discount to their fair value with sufficient upside to warrant the underlying risk assumed

Qualitative information should be quantified in a structured objective manner which creates discipline in investment decision making and mitigates emotional biases

Risk Control
Risk should be quantified using the underlying risk factors rather than statistical metrics as an integral part of the investment process
Investment Process
The investment process aims to invest in quality, under-valued companies using a value-driven, bottom-up stock selection process encapsulated in a structured framework. The investment manager conducts in-country, in-depth fundamental company research. The investment process employs an in-house risk control process where political and macroeconomic risks are identified, assessed and managed.
Joseph Rohm
Portfolio Manager
Joseph has twenty years of investment experience and previously managed the Africa public equity portfolios of Investec, Investec Investment Forum and the Investec Africa Macroeconomic Forum. Portfolio Manager of the T Rowe Price Africa and Middle East portfolios, Senior Emerging Market financial analyst T Rowe Price, Global financial analyst ABN AMRO. He holds a BSc (Hons) in Chemical Engineering and a BCom from the University of Cape Town, and an MBA from The Netherlands Business School.
Diane Laas
Senior Analyst (Adventis SA)
Diane has twelve years of African investment experience. Diane spent four years as the Chief Investment Officer of Uqalo, a private equity firm investing in consumer related businesses across Africa. Before Uqalo, she spent eight years at Investec Asset Management as an Equity Analyst and later Co-Portfolio of an Emerging Market Equity Fund.
Michael Ashaolu
Michael has over seven years of African experience working in various investment and banking roles. This included five years at Fidelity Bank in Nigeria. He holds a Master’s degree Financial & Risk Management from the University of Cape Town and is currently a Level 3 candidate in the Chartered Financial Analyst program. He is a Chartered Accountant with the Institute of Chartered Accountants of Nigeria.
Joy Motlaleng
Joy Motlaleng has four years of African focused experience having worked in investment consulting and at investment holding company level. This included positions at Alexander Forbes Botswana and Afinitas Limited, a Botswana listed company. She holds a BTech degree in Financial Information Systems as well as a Post Graduate Certificate in Enterprise Risk Management.

February 2021

Strategy Performance

Financial markets were mixed during the month of February with the S&P 500 +2.6% for the month of February which followed on from the weak performance in January (-1.1% USD). During February markets were strong as confidence grew around the continued rollout of vaccines in the U.S. and U.K. The S&P is now 70% above its lows of 2020 and tech has returned 40% annually for the last two years. We do not believe that this is sustainable and that a correction will come. This should benefit African markets that remain uncorrelated to developed and emerging markets.

Emerging market performance was decent and the MSCI EM rose +0.7% USD for the month of February, which followed on from a positive January (+3.0%).

African markets were mixed during February. The MSCI EFM Africa ex-SA NTR index dropped -1.2% USD for the month. Nigeria -6.2%(USD) and Egypt (-0.51%), two of our larger markets, were very weak. Other Africa markets such as Ghana (+8.6%) and Kenya (+6.3%) closed positively.

The Adventis Africa Equity Strategy -3.16% USD was down for the month and underperformed it’s benchmark by 126bps over February. The strategy has outperformed its benchmark since inception (Dec 2014) by 2.2% p.a.

The top contributors to USD performance for the month were Scancom (20.6%), Sonatel (+16.1%) and Seplat (10.6%). The largest detractors last month were Capricorn (- 21.9%), Nigerian Breweries (-17.5%) and Juhayna (-17.7%).

Focus on Impact Investing

The team continued with their evaluation of the current portfolio holdings with respect to their Impact alignment to the United Nations Social Development Goals (SDGs). We are now using the Cambridge Institute of Sustainable Leadership (CISL) methodology to measure the company and portfolio contribution to impact. The Impact Scores are being used to drive portfolio construction as well as risk control.

This month we revisited the Kenyan telco, Safaricom, and reviewed their contribution to impact as measured by CISL. We generate six scores, one each for basic needs, wellbeing, decent work, resource security, healthy ecosystems, and climate stability.

Our analysis shows that Safaricom would sit in the top quintile in all six categories relative to the MSCI European Index average. It is an impressive and significant contributor toward impact investment. Decent work is the third category identified by the Cambridge Institute of Sustainable Leadership (CISL). For example, Safaricom has 4515 permanent employees, which is 93,912 full time equivalent hours per US$ 1mn invested by the fund. This is a top quintile contribution relative to MSCI Europe and a key contributor to social wellbeing in Kenya.

Strategy Offering Value and Growth

The Adventis Strategy continues to have a quality bias and offers both value and growth with a PE ratio of 14.3, dividend yield of 4.6%, and a ROE of 26.8%. The strategy is well positioned to take advantage of current market conditions.

Market Commentary

On the 18th of February, Africa recorded 100,000 COVID-19-related fatalities, a threshold breached previously in Europe in April 2020. The rise in African cases continues to slow, as total coronavirus cases reached 3.92 million at month-end, a 9.50% increase month-on-month. The historical global vaccination campaign is well underway, as more than 225 million doses have been administered across 100 countries (Bloomberg). The current rate of vaccination is approximately 6.07 million doses per day. The US estimates at their current rate, it will take 10 months to cover 75% of the population with a two-dose vaccine. The UK announced that their objective is to lift all restrictions by the 21st of June. In addition, as the EU ramps up their vaccine rollout, there may finally be light at the end of the tunnel, thus allowing capacity to be directed
towards frontier markets.

China has, to date, been the driving force behind facilitating Africa’s access to the vaccines. Zimbabwe, Mozambique, Senegal, and Tunisia have secured 700,000 doses and are currently prioritising healthcare professionals. South Africa, Seychelles, and Morocco have all undertaken administering the vaccine. Mauritius is aiming for a timeline of mid-2021 for 60-70% of their population to be vaccinated and Ghana was the first recipient of vaccines from Covax, the initiative designed to ensure equitable distribution of the vaccine.

Egypt remains one of our preferred markets in the portfolio. The Egyptian equity market has been very weak in recent months, however there is no fundamental reason for this. Egypt’s non-petroleum trade balance improved 17% y-o-y in 2020 to reach USD38.2bn. Imports dropped 12 % y-o-y to USD63.5bn, partially driven by localisation of some inputs in various manufacturing sub-sectors. Meanwhile, exports fell 1% y-o-y to USD25.2bn. Three export sectors witnessed tangible growth last year: construction materials (+20%), medical industries (+1%) and handicrafts (less than 1%). Remittances from Egyptians working abroad have been surprisingly resilient and reached USD27.1bn in 11M20, up 12% y-o-y. Inflows were up 2.6% y-o-y in November to USD2.6bn. Following a 10.5% y-o-y drop in 2Q20, during the peak of the pandemic, remittances recovered strongly to a record of USD27.5bn in FY19/20.

We like certain Moroccan companies, however, find the market overvalued. Morocco has started its Coronavirus vaccination program and has one of the most advanced vaccination programs on the continent. It received its first shipments of vaccine doses in recent days from China’s Sinopharm and Anglo-Swedish AstraZeneca. Morocco will get 66 million vaccine doses, covering about 80% of its 35 million population.

Morocco’s Bank Al Maghrib extended the lower minimum capital requirements for banks until June 2022. The central bank had lowered minimum capital requirements by 50bps as a policy response to the pandemic. Banks in Morocco must comply with a minimum Tier-1 ratio of 8.5% and a minimum total capital adequacy ratio of 11.5%.

Kenya is an attractive market experiencing high GDP growth. The IMF reached a stafflevel agreement for a USD2.4bn, 38-month long loan programme (EFF & EFC) with Kenyan authorities. Kenya is to raise its debt ceiling, to Ksh 9tn, as headroom for more debt reduces. Public debt crossed Sh7.28bn last December, an equivalent of 65.6% of gross domestic product (GDP), from Sh6.01trn or 58.0% of GDP a year earlier. Central Bank of Kenya (CBK) data shows that diaspora remittances in January grew 7.3% from USD 259.4 mn. Like remittances in Egypt, we have been surprised at how resilient they have been.

Nigeria is a challenging market; however, we find good Nigerian companies for the portfolio. Nigeria saw a surprise exit from recession in the fourth quarter of 2020. Projections from the IMF and the World Bank, pointed towards an exit from recession at the end of 2021. However, Nigeria appears to have beaten the projections of its recovery by one year. The economy grew by 0.11% in the 4Q20 with full year GDP coming to -1.92% against IMF and the World Bank projection of between a 3.25% and 4% contraction. The resilience of the quarter was driven by developments in the non-oil sector as it grew 1.69% in Q4 compared to the oil sector which contracted by 19.76%. While the non-oil sector recorded some improvements in the quarter, both the oil and non-oil sectors, however, closed the year contracting 8.89% and 1.25% respectively, caused by a decline in production to an average 1.56mn barrel in Q4, the lowest since at least 2009. Nigeria’s continued compliance with the OPEC oil production cuts has negatively impacted production. Nigeria revised its debt level target as it approved a new Medium-Term Debt Management Strategy (MTDS) for the period 2020-2023. Targets of the MTDS include (1) 40% maximum total public debt as a percentage of GDP (Previously: 25%), (2) a debt portfolio mix skewed towards domestic debt rather than external debt in the ratio 70:30 (Previously: 60:40), and (3) sustenance of the issuance
of longer-tenor instruments with tenors of 10 years and above, with a ratio of 75:25 for long-term to short-term domestic debt. Nigeria’s revised debt-to-GDP ratio target is still low when compared to IMF’s threshold (55%) for its peers.

Contact Us

Please contact Joseph Rohm ( should you require any further information.

This material is intended to be utilised for information purposes only. Should you choose to use this material for any other purposes other than information, you should do so with the assistance of professional advice. Adventis SA (Pty) Ltd not is acting or purporting to act in any way as an advisor. If you rely on this information for any purpose whatsoever, you do so at your own risk.

Adventis SA (Pty) Ltd does not accept any liability of whatever nature and howsoever arising in respect of any claim, damage, loss or expense, whether caused directly or indirectly including consequential loss or loss of profit, arising out of or in connection with you, the user, on the contents of this material, or the user of the information products and services described in this material.

This material is for information purposes only and does not constitute or form part of any offer to the public to issue or sell, or any solicitation of any offer to subscribe for or purchase an investment, nor shall it or the fact of its distribution form the basis of, or be relied upon in connection with any contract for investment. Investors should take cognisance of the fact that there are risks involved in buying or selling any financial product. Illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only.

The value of financial products can increase as well as decrease over time, depending on the value of the underlying securities and market conditions. Past performance is not necessarily a guide to future performance and no guarantees are provided.